Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Mar 2020 10:47

RNS Number : 8515E
InnovaDerma PLC
03 March 2020
 

LEI: 213800WRAP6W8VDL6B38

 

InnovaDerma PLC

 ("InnovaDerma" or the "Company")

Director/PDMR Shareholding

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, announces, it was notified today, Joseph Bayer, Executive Chairman has purchased 16,400 Ordinary Shares of €0.10 each at a price of 58 pence per Ordinary Share (the "Purchase").

Following the Purchase, Joseph Bayer personally now holds a total of 49,240 shares. He also has a separate holding of 129,000 Ordinary Shares held via his Australian Superannuation Fund which Mr Bayer controls. Therefore, Joseph Bayer's total interest in the Company through direct and indirect holdings is 178,240 Ordinary Shares representing approximately 1.23% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

www.innovaderma.com

 

 

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/ Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Joseph Bayer

 

2.

Reason for the Notification

 

a)

Position/status

Executive Chairman

 

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume and Price - 16,400 Ordinary Shares at 58 pence per share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

3 March 2020

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUOSRRRNUORAR
Date   Source Headline
5th May 20172:05 pmRNSSecond Price Monitoring Extn
5th May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20172:06 pmRNSSecond Price Monitoring Extn
3rd May 20172:00 pmRNSPrice Monitoring Extension
3rd May 20177:15 amRNSCompany update and Directorate Change
2nd May 20177:00 amRNSAcquisition
28th Apr 20178:05 amRNSBroker Warrants
11th Apr 20177:00 amRNSAllotment of Shares
3rd Apr 20177:00 amRNSTrading update
3rd Mar 20174:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20174:35 pmRNSPrice Monitoring Extension
3rd Mar 20172:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20172:00 pmRNSPrice Monitoring Extension
2nd Mar 201711:18 amRNSExercise of Share Options
1st Mar 20177:00 amRNSCompletion of Acquisitions
27th Feb 20177:00 amRNSAcquisition of Stevie K and Charles + Lee Brands
9th Feb 20177:00 amRNSHalf-year Report
30th Jan 20177:00 amRNSDirectorate Change
27th Jan 201711:17 amRNSNotice of Results
25th Jan 20178:00 amRNSHeads of Agreement with PROS Korea
16th Jan 20177:00 amRNSTrading Statement
10th Jan 20177:00 amRNSDirectorate Change
9th Jan 20179:06 amRNSSecond Price Monitoring Extn
9th Jan 20179:00 amRNSPrice Monitoring Extension
19th Dec 20163:18 pmRNSHolding(s) in Company
15th Dec 201610:08 amRNSResult of AGM
14th Dec 20169:45 amRNSPlacing
8th Dec 20167:00 amRNSCompletion of Placing
6th Dec 20167:30 amRNSGeneral Manager appointed for the UK and Europe
25th Nov 20167:00 amRNSPlacing and Fundraising
17th Nov 20164:34 pmRNSNotice of AGM & Posting of Annual Report
16th Nov 20161:54 pmRNSBroker Warrants
14th Nov 20167:00 amRNSPublication of Supplementary Prospectus
11th Nov 201611:23 amRNSDirector/PDMR Shareholding
31st Oct 201610:25 amRNSFinal Results
31st Oct 20167:00 amRNSInnovaDerma enters US market
24th Oct 20167:00 amRNSOperational update & presentation published online
21st Oct 20162:15 pmRNSIssue of Equity
20th Oct 201611:05 amRNSSecond Price Monitoring Extn
20th Oct 201611:00 amRNSPrice Monitoring Extension
10th Oct 20167:00 amRNSTrading Statement
9th Sep 201612:38 pmRNSVoluntary Suspension of Trading on Marche Libre
7th Sep 20167:00 amRNSAdmission to the Official List

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.